| FDMT Stock | | | USD 8.53 0.08 0.95% |
4D Molecular financial indicator trend analysis is way more than just evaluating 4D Molecular Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 4D Molecular Therapeutics is a good investment. Please check the relationship between 4D Molecular Accounts Payable and its Total Current Assets accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 4D Molecular Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
Accounts Payable vs Total Current Assets
Accounts Payable vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
4D Molecular Therapeutics Accounts Payable account and
Total Current Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between 4D Molecular's Accounts Payable and Total Current Assets is 0.91. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of 4D Molecular Therapeutics, assuming nothing else is changed. The correlation between historical values of 4D Molecular's Accounts Payable and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of 4D Molecular Therapeutics are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Accounts Payable i.e., 4D Molecular's Accounts Payable and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.91 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Accounts Payable
An accounting item on the balance sheet that represents 4D Molecular obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of 4D Molecular Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from 4D Molecular's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 4D Molecular Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 4D Molecular Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
At this time, 4D Molecular's
Sales General And Administrative To Revenue is comparatively stable compared to the past year.
Enterprise Value is likely to gain to about 587.6
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 21.7
M in 2024.
4D Molecular fundamental ratios Correlations
Click cells to compare fundamentals
4D Molecular Account Relationship Matchups
High Positive Relationship
High Negative Relationship
4D Molecular fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to
measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to
predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.